Severe Hypomagnesemia and Hypocalcemia Linked to Semaglutide in Type 2 Diabetes: A Case Report
American Journal of Case Reports · 2024
DOI: 10.12659/ajcr.946539 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Case Reports, 2024. Verfasst von Timothy Mark Earls Davis. Beteiligte Einrichtung: Medical School, University of Western Australia, Fremantle, Western Australia, Australia. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Glucagon-Like Peptides, Hypocalcemia, Hypoglycemic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Medical School, University of Western Australia, Fremantle, Western Australia, Australia.
- Department of Endocrinology and Diabetes, Fiona Stanley and Fremantle Hospitals, Murdoch, Western Australia, Australia.
Zitieren
APA
Davis, T. M. E. (2024). Severe Hypomagnesemia and Hypocalcemia Linked to Semaglutide in Type 2 Diabetes: A Case Report. American Journal of Case Reports. https://doi.org/10.12659/ajcr.946539
Vancouver
Davis TME. Severe Hypomagnesemia and Hypocalcemia Linked to Semaglutide in Type 2 Diabetes: A Case Report. American Journal of Case Reports. 2024. doi:10.12659/ajcr.946539
BibTeX
@article{Davis2024,
author = {Davis, Timothy Mark Earls},
title = {Severe Hypomagnesemia and Hypocalcemia Linked to Semaglutide in Type 2 Diabetes: A Case Report},
journal = {American Journal of Case Reports},
year = {2024},
doi = {10.12659/ajcr.946539}
}
EUVIMED